In the patient group, the mean hemoglobin values showed a decreasing trend on the three serial measurements on day 1 (11.09 ± 2.43 g/dL), day 5 (10.8 ± 2.73 g/dL), and day 10 (10.2 ± 2.69 g/dL).
← all excerpts
Soluble Urokinase Plasminogen Activator Receptor: A Useful Marker for Predicting Mortality in COVID-19 Patients.
1
—
—